Optical Genome Mapping Market Size, Share, Growth & Trends 2024-2033 | Key Players & Forecast

The Business Research Company recently released a comprehensive report on the Global Optical Genome Mapping Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.

Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15882&type=smp

According to The Business Research Company's, The optical genome mapping market size has grown exponentially in recent years. It will grow from $0.14 billion in 2023 to $0.17 billion in 2024 at a compound annual growth rate (CAGR) of 29.4%. The growth in the historic period can be attributed to increasing demand for advanced genomic analysis tools and techniques, increasing research on large-scale genome identification, increasing number of collaborations between instrument manufacturers and hospitals, adoption of optical genome mapping in research institutions and pharmaceutical companies and cost-effectiveness and efficiency lead to rapid analysis of large genomes with high accuracy.

The optical genome mapping market size is expected to see exponential growth in the next few years. It will grow to $0.49 billion in 2028 at a compound annual growth rate (CAGR) of 29.5%. The growth in the forecast period can be attributed to advancements in genomic research, increasing demand for precision medicine, rising government funding and initiatives, robust healthcare infrastructure, and increasing prevalence of genetic diseases and cancer. Major trends in the forecast period include advanced OGM services, genomic research initiatives, advancements in DNA mapping technologies, technological advancements, and advancements in data analysis technologies such as AI and ML for genomic data processing.

Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/optical-genome-mapping-global-market-report

Market Drivers and Trends:
The growing patient population suffering from diabetes is expected to propel the growth of the medical device engineering services market going forward. Diabetes is a medical condition characterized by high blood glucose (sugar) levels resulting from defects in insulin production, insulin action, or both. The rising prevalence of diabetes is attributed to factors like sedentary lifestyles, aging populations, genetic predisposition, and dietary changes, driving an increase in the patient population. Medical device engineering services drive diabetes management by innovating glucose monitors, insulin delivery systems, artificial pancreas technology, wearables, and user-friendly designs. For instance, in February 2023, according to the Cleveland Clinic, a US-based non-profit academic medical center, globally, an estimated 537 million adults were diagnosed with diabetes, with projections suggesting an increase to 643 million by 2030 and 783 million by 2045. Therefore, the growing patient population suffering from diabetes is driving the growth of the medical device engineering services market.

Major companies operating in the optical genome mapping market are developing optical genome mapping-based laboratory-developed tests (LDT) to enhance diagnostic capabilities and offer more accurate genomic insights. Optical genome mapping-based laboratory-developed tests (LDTs) are diagnostic assays designed and implemented within individual clinical laboratories using optical genome mapping (OGM) technology. For instance, in September 2022, Bionano Genomics Inc., a US-based company providing genome analysis software, launched optical genome mapping-based LDT for facioscapulohumeral muscular dystrophy (FSHD). The OGM-based LDT will enable Bionano Laboratories to offer services to customers seeking to implement OGM into their diagnostic routines and for research applications with hospitals, pharmaceutical companies, and other parties.

Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.

Major Key Players of the Market:
Agilent Technologies Inc., Illumina Inc., PerkinElmer Genomics, Bio-Rad Laboratories Inc., Qiagen N.V., Cerba Healthcare, GenScript Biotech Corporation, 10x Genomics Inc., Oxford Nanopore Technologies plc, Pacific Biosciences of California Inc., NanoString Technologies Inc., MedGenome, Element Biosciences, Bionano Genomics Inc. , Stratos Genomics, BioSkryb Genomics, Source Genomics, Genoox, Nucleome Informatics Private Limited, Praxis Genomics LLC, Phase Genomics Inc., Daicel Arbor Biosciences, Nabsys, OpGen, Genohub Inc.

Optical Genome Mapping Market 2024 Key Insights:
• The optical genome mapping market size is expected to see exponential growth in the next few years. It will grow to $0.49 billion in 2028 at a compound annual growth rate (CAGR) of 29.5%.
• Precision Medicine Driving Growth In The Optical Genome Mapping Market
• Development Of Optical Genome Mapping-Based LDTs For Enhanced Diagnostic Capabilities
• North America was the largest region in the optical genome mapping market in 2023

We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=15882&type=smp

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Learn More About The Business Research Company

The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.